Cancer Genetics tests in Dubai & UAE

Compare available Cancer Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

700.00–6,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Cancer Genetics test prices

Showing 16–30 of 59 matching tests.

Cancer Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1965 EGFR Gene Non-Small Cell Lung Cancer Familial Susceptibility Genetic Test This test evaluates the entire coding region of the EGFR gene for germline variants associated with an increased risk of non-small cell lung cancer.	Whole Blood (Peripheral) or FTA Card Dried Blood Spot	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR gene germline variants", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of anticoagulant therapy"] Indications ["Family history of non-small cell lung cancer", "Personal history suggestive of hereditary cancer syndrome", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21696-5 ICD-10: Z15.01, C34.90, Z84.81 Clinical summary This test evaluates the entire coding region of the EGFR gene for germline variants associated with an increased risk of non-small cell lung cancer.
TEST-2092 EpCAM Gene (Lynch Syndrome Type 8) Genetic Test This genetic test sequences the EpCAM gene to detect mutations associated with Lynch syndrome type 8, a hereditary cancer predisposition syndrome.	Peripheral whole blood (venous draw) or dried blood spot on FTA card	14–21 business days from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EpCAM gene sequence", "Copy Number Variations (CNV) in EpCAM gene"] Parameters [] Preparation ["No fasting required", "No medication adjustment needed", "Complete mandatory virtual genetic counselling session"] Indications ["Individuals with a personal or family history suggestive of Lynch syndrome", "Cascade testing for family members of known mutation carriers"] Measurement technique Confirm with laboratory Codes LOINC: 79747-6 ICD-10: Z15.01, C18.9, Z12.11 Clinical summary This genetic test sequences the EpCAM gene to detect mutations associated with Lynch syndrome type 8, a hereditary cancer predisposition syndrome.
TEST-2035 EZH2 Gene Leukemia, Lymphoblastic & Myeloid EZH2‑Related Genetic Test This diagnostic test evaluates the EZH2 gene for mutations associated with lymphoblastic and myeloid leukaemia.	Whole Blood (Peripheral) – EDTA Tube	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EZH2 gene coding region", "Splice-site boundaries", "Gain-of-function variants", "Loss-of-function variants", "Structural rearrangements", "Point mutations", "Indels", "CNVs", "Deep intronic variants"] Parameters [] Preparation ["No specific fasting required.", "Inform the laboratory of any recent blood transfusions (within 14 days)."] Indications ["Diagnosis of acute lymphoblastic leukaemia (ALL)", "Diagnosis of acute myeloid leukaemia (AML)", "Prognostic assessment in leukaemia", "Guidance for targeted therapy selection", "Clinical trial eligibility assessment"] Measurement technique Confirm with laboratory Codes LOINC: 92736-8 ICD-10: C91.0, C92.0 Clinical summary This diagnostic test evaluates the EZH2 gene for mutations associated with lymphoblastic and myeloid leukaemia.
TEST-1578 FOXO1 Break-Apart FISH (Alveolar Rhabdomyosarcoma) Diagnostic Test This diagnostic test evaluates formalin-fixed paraffin-embedded tumor tissue for the presence of PAX3-FOXO1 or PAX7-FOXO1 gene fusions using Fluorescence In-Situ Hybridization (FIS...	Formalin-Fixed Paraffin-Embedded (FFPE) tumor tissue block or biopsy slides	7–8 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PAX3-FOXO1 fusion", "PAX7-FOXO1 fusion", "Chromosomal rearrangements of the FOXO1 gene"] Parameters [] Preparation [] Indications ["Diagnosis of alveolar rhabdomyosarcoma", "Prognosis determination in rhabdomyosarcoma", "Guidance for targeted therapy"] Measurement technique Confirm with laboratory Codes LOINC: 94470-2 ICD-10: C49.9 Clinical summary This diagnostic test evaluates formalin-fixed paraffin-embedded tumor tissue for the presence of PAX3-FOXO1 or PAX7-FOXO1 gene fusions using Fluorescence In-Situ Hybridization (FISH).
TEST-1339 Genetic Mapping for Oncology / Cancer Test This test evaluates germline DNA for hundreds of cancer-susceptibility genes using a SNP microarray and chromosomal microarray.	Peripheral whole blood (3 mL) in EDTA tube	8 weeks from sample receipt	2,700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single Nucleotide Polymorphisms (SNPs)", "Copy Number Variants (CNVs)", "Polygenic Risk Scores"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Individuals with a strong family history of cancer", "Patients seeking comprehensive cancer risk assessment", "Personal history of cancer"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Z15.09, Z13.89 Clinical summary This test evaluates germline DNA for hundreds of cancer-susceptibility genes using a SNP microarray and chromosomal microarray.
TEST-1907 HNF1A Germline Mutation Genetic Test for Renal Cell Carcinoma (NGS) This genetic test identifies inherited mutations in the HNF1A gene associated with an increased risk of renal cell carcinoma.	Whole blood (peripheral venipuncture)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HNF1A gene mutations (SNVs, indels, copy number variants)", "Inherited genetic predisposition to renal cell carcinoma"] Parameters [] Preparation ["Complete mandatory pre-test genetic counselling", "Sign informed consent form"] Indications ["Individuals with a personal or family history of kidney cancer", "Asymptomatic relatives of known HNF1A mutation carriers"] Measurement technique Confirm with laboratory Codes LOINC: 101230-7 ICD-10: C64.9, Z15.09, Z80.51 Clinical summary This genetic test identifies inherited mutations in the HNF1A gene associated with an increased risk of renal cell carcinoma.
TEST-1905 HOXB13 Gene (Prostate Cancer, Familial) Genetic Test This test evaluates the HOXB13 gene for germline variants associated with an increased risk of developing prostate cancer.	Whole Blood (3 to 5 mL in EDTA tube) or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HOXB13 gene sequence", "Germline variants in HOXB13"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counseling session"] Indications ["Strong family history of prostate cancer", "Personal history of early-onset prostate cancer"] Measurement technique Confirm with laboratory Codes LOINC: 81258-4 ICD-10: Z15.03 Clinical summary This test evaluates the HOXB13 gene for germline variants associated with an increased risk of developing prostate cancer.
TEST-2042 IDH1 Exon 4 Mutation Analysis (NGS) Test This test identifies mutations in exon 4 of the IDH1 gene using Next-Generation Sequencing (NGS). It helps guide treatment decisions for specific cancers.	Peripheral whole blood (EDTA) or FFPE tissue block	3–4 Weeks (21–28 business days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IDH1 gene exon 4 mutations", "Single-nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Diagnosis of gliomas", "Diagnosis of acute myeloid leukemia (AML)", "Diagnosis of cholangiocarcinoma", "Guidance for targeted therapy selection (e.g., ivosidenib)"] Measurement technique Confirm with laboratory Codes LOINC: 91783-8 ICD-10: C71.9 Clinical summary This test identifies mutations in exon 4 of the IDH1 gene using Next-Generation Sequencing (NGS). It helps guide treatment decisions for specific cancers.
TEST-2066 IDH2 Gene Exon 4 Sequencing (NGS) Test This test detects specific mutations within the fourth exon of the IDH2 gene, which are associated with AML and MDS.	Peripheral Whole Blood or FTA Card Dried Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IDH2 gene exon 4 mutations (e.g., R140Q, R172K)"] Parameters [] Preparation ["No special preparation required", "Fasting is not necessary", "Pre-test genetic counseling is mandatory", "Inform phlebotomist of active bleeding disorders or anticoagulant therapy"] Indications ["Diagnosis of Acute Myeloid Leukemia (AML)", "Diagnosis of Myelodysplastic Syndromes (MDS)", "Guiding targeted therapy for AML/MDS", "Assessing risk of disease progression", "Monitoring for clonal evolution"] Measurement technique Confirm with laboratory Codes LOINC: 92618-6 ICD-10: C92.00, D46.9 Clinical summary This test detects specific mutations within the fourth exon of the IDH2 gene, which are associated with AML and MDS.
TEST-2046 KRAS Gene Mutation Analysis for Acute Myelogenous Leukemia, Genetic Test This test identifies somatic mutations in the KRAS gene using Next-Generation Sequencing (NGS) to aid in the prognosis and treatment selection for Acute Myelogenous Leukemia (AML).	Peripheral Whole Blood (or FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KRAS gene somatic mutations", "Allele frequency of detected variants"] Parameters [{"name": "KRAS Mutation Status", "reference_range": "Negative/Positive for specific mutations"}] Preparation ["No specific fasting required.", "Inform your physician about all current medications."] Indications ["Diagnosis of Acute Myelogenous Leukemia (AML)", "Prognosis assessment in AML", "Selection of targeted therapies for AML"] Measurement technique Confirm with laboratory Codes LOINC: 21659-8 ICD-10: C92.00 Clinical summary This test identifies somatic mutations in the KRAS gene using Next-Generation Sequencing (NGS) to aid in the prognosis and treatment selection for Acute Myelogenous Leukemia (AML).
TEST-2005 MC1R Gene Melanoma, Cutaneous Malignant Genetic Test This genetic test evaluates the MC1R gene for mutations associated with an increased risk of cutaneous malignant melanoma.	Whole Blood (EDTA tube), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MC1R gene variants", "Germline mutations"] Parameters [] Preparation ["Mandatory genetic counselling session", "Provide complete clinical history", "Provide skin phenotype information"] Indications ["Individuals with a personal or family history of melanoma", "Individuals with multiple atypical moles", "Individuals with red hair and fair skin"] Measurement technique Confirm with laboratory Codes LOINC: 92828-0 ICD-10: C43.9, D03.9, Z15.09 Clinical summary This genetic test evaluates the MC1R gene for mutations associated with an increased risk of cutaneous malignant melanoma.
TEST-1189 MET Gene Amplification (FISH) Test This diagnostic test evaluates the number of copies of the MET gene within tumor cells.	Tumor Tissue (FFPE Block / Biopsy Slides)	4 Working Days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MET gene copy number", "Amplification status"] Parameters [] Preparation [] Indications ["Non-small cell lung cancer", "Other solid tumors where MET amplification is relevant"] Measurement technique Confirm with laboratory Codes LOINC: 48647-3 ICD-10: C80.1 Clinical summary This diagnostic test evaluates the number of copies of the MET gene within tumor cells.
TEST-1336 Microsatellite Instability (MSI) Testing for Lynch Syndrome & Colorectal Cancer Test This diagnostic test evaluates the stability of microsatellites within a patient's DNA to detect defects in DNA mismatch repair mechanisms.	Archival Tumor Tissue Block (FFPE) and Peripheral Blood	7–8 business days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Microsatellite length variations", "DNA mismatch repair (dMMR) status"] Parameters [] Preparation [] Indications ["Screening for Lynch syndrome", "Guiding colorectal cancer treatment (e.g., 5-FU therapy)", "Prognosis assessment in colorectal cancer"] Measurement technique Confirm with laboratory Codes LOINC: 59040-5 ICD-10: Z12.11, Z80.3 Clinical summary This diagnostic test evaluates the stability of microsatellites within a patient's DNA to detect defects in DNA mismatch repair mechanisms.
TEST-1983 MLH1 Gene Mismatch Repair Cancer Syndrome Genetic Test This genetic test evaluates the MLH1 gene for mutations associated with Lynch syndrome, a hereditary cancer predisposition.	Peripheral Whole Blood (3–5 mL in EDTA tube)	3–4 Weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MLH1 gene mutations", "Germline variants"] Parameters [] Preparation [] Indications ["Family history of Lynch syndrome-associated cancers", "Personal history of early-onset colorectal or other Lynch-associated cancers"] Measurement technique Confirm with laboratory Codes LOINC: 21629-9 ICD-10: Z15.09, Z80.0 Clinical summary This genetic test evaluates the MLH1 gene for mutations associated with Lynch syndrome, a hereditary cancer predisposition.
TEST-2118 MLH3 Gene Colorectal Cancer, Hereditary Nonpolyposis Type 7 (Lynch Syndrome) Genetic Test This test evaluates the MLH3 gene for pathogenic variants linked to Hereditary Nonpolyposis Colorectal Cancer (HNPCC), also known as Lynch syndrome type 7.	Peripheral Blood (Whole Blood) – EDTA Tube	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MLH3 gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Individuals with a personal or family history suggestive of Lynch syndrome", "Risk assessment for hereditary colorectal cancer"] Measurement technique Confirm with laboratory Codes LOINC: 82378-1 ICD-10: Z15.08 Clinical summary This test evaluates the MLH3 gene for pathogenic variants linked to Hereditary Nonpolyposis Colorectal Cancer (HNPCC), also known as Lynch syndrome type 7.

Category overview

Cancer Genetics: overview

Empowering yourself with a deep understanding of your family’s oncological history is the most effective way to protect your future wellness. As a core pillar of our advanced Molecular Genetics department, comprehensive Cancer Genetics screening provides an in-depth evaluation of the complex hereditary pathways linked to various cancer syndromes. By leveraging cutting-edge genomic technology, this expansive screening delivers the critical clarity required to assess inherited risks, safely guiding customized oncology oversight, specialized prophylactic strategies, and informed family planning. Consistently ranked among the best diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic precision, and prompt, reliable turnaround times. Prioritize your preventative health—book your cancer genetics testing in UAE, arrange a comfortable home sample collection, or consult our specialized genetic counselors.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.